Detalhe da pesquisa
1.
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
Nat Immunol
; 23(8): 1183-1192, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902637
2.
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Cancer
; 130(5): 692-701, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864521
3.
Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy.
J Urol
; 210(2): 273-279, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167628
4.
Relationship between insurance status and interhospital transfers among cancer patients in the United States.
BMC Cancer
; 22(1): 121, 2022 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093015
5.
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma.
Cancer
; 127(21): 3946-3956, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286865
6.
Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
Br J Haematol
; 193(5): 951-960, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993466
7.
Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma.
J Natl Compr Canc Netw
; 19(4): 432-438, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33578374
8.
A qualitative framework of non-selection factors for cytoreductive nephrectomy.
World J Urol
; 39(9): 3359-3365, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33779820
9.
Immune checkpoint blockade in renal cell carcinoma.
J Surg Oncol
; 123(3): 739-750, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595892
10.
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations.
BMC Urol
; 20(1): 84, 2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616076
11.
Unbiased Pathogen Detection and Host Gene Profiling for Conjunctivitis.
Ophthalmology
; 126(8): 1090-1094, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953744
12.
13.
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.
Eur Urol
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782695
14.
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma.
Urol Oncol
; 42(2): 32.e9-32.e16, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135627
15.
Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.
Eur Urol
; 83(3): 195-199, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344318
16.
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
Eur Urol Oncol
; 2023 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945488
17.
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
Eur Urol Focus
; 9(5): 734-741, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863962
18.
Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.
Cell Metab
; 35(8): 1424-1440.e5, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37413991
19.
Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma.
Front Oncol
; 12: 910147, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837094
20.
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade.
Clin Cancer Res
; 28(23): 5180-5189, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190538